SUPN insider trading
See Supernus Pharmaceuticals (SUPN) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.
Insider trades
| Insider | Role | Trade | Traded | Filed | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|
| Anderson Woodrow D | Chief Accounting Officer | Buy | Aug 27, 2026 | Aug 27, 2026 | 1,500 | $35.69 | $53.53K | Filing |
| Anderson Woodrow D | Chief Accounting Officer | Buy | Aug 5, 2026 | Aug 5, 2026 | 1,500 | $36.28 | $54.42K | Filing |
| Heidbreder Christian | Chief Scientific Officer | Sell | Jul 10, 2026 | Jul 13, 2026 | 18,586 | $41.14 | $764.63K | Filing |
| Heidbreder Christian | Chief Scientific Officer | Sell | Jun 11, 2026 | Jun 12, 2026 | 18,586 | $38.06 | $707.38K | Filing |
| Preblick Ryan | Chief Financial Officer | Sell | Jun 8, 2026 | Jun 10, 2026 | 36,000 | $37.70 | $1.36M | Filing |
| Ryan Barbara | Director | Buy | Mar 13, 2026 | Mar 13, 2026 | 8 | $31.09 | $248.68 | Filing |
| Kingsley Stuart A | Director | Buy | Mar 6, 2026 | Mar 11, 2026 | 940 | $31.86 | $29.95K | Filing |
| Ryan Barbara | Director | Buy | Mar 9, 2026 | Mar 11, 2026 | 31 | $32.56 | $1.01K | Filing |
| Ryan Barbara | Director | Buy | Jan 5, 2026 | Jan 7, 2026 | 775 | $35.39 | $27.43K | Filing |
| Humphreys Keith | Director | Buy | Jan 5, 2026 | Jan 7, 2026 | 775 | $35.39 | $27.43K | Filing |
| NINIVAGGI DANIEL A | Director | Buy | Jan 5, 2026 | Jan 7, 2026 | 775 | $35.39 | $27.43K | Filing |
| Stejbach Mark | Director | Buy | Jan 5, 2026 | Jan 7, 2026 | 775 | $35.39 | $27.43K | Filing |
| Wheadon David E. | Director | Buy | Jan 5, 2026 | Jan 7, 2026 | 1,771 | $35.39 | $62.68K | Filing |